Hsa-miR-149-5p Suppresses Prostate Carcinoma Malignancy by Suppressing RGS17

Background: MicroRNAs (miRNAs) are key players in the progression of human cancers. While several miRNAs have been reported to regulate the development of tumors, the molecular mechanisms and roles of miR-149-5p in prostate carcinoma (PCa) remain unclear. Our aim was to investigate the interaction and functions of miR149-5p and RGS17 in PCa. Methods: Microarray analysis was performed to identify the key miRNA and gene involved in PCa progression. The expression levels of miRNA and mRNA in PCa tissues and cells were verified by qRT-PCR. MTT assay, BrdU proliferation assay and wound-healing assay were applied to assess the effect of miR-149-5p and RGS17 on PCa cells' viability, proliferation, and migration ability. The association between RGS17 and miR-149-5p was identify using dual-luciferase reporter assay and Western blot assay. Results: Data analysis indicated the reduction of miR-149-5p expression in PCa tissues and cells. Experimental investigations also showed that this miRNA suppressed the viability, proliferation and migration ability of PCa cells. RGS17 was found to be the target of miR149-5p, and the low expression of miR-149-5p upregulated RGS17 in PCa tissues and cells. The results of the cell-function assays showed that RGS17 acted as an oncogene in PCa even though its promotive effect could be reversed by miR-149-5p. Conclusion: This research confirmed that by targeting and inhibiting RGS17, miR-149-5p could suppress PCa development.

Automated summary

The study revealed that miR-149-5p is downregulated in prostate carcinoma (PCa), and can suppress the viability, proliferation, and migration ability of PCa cells. Additionally, miR-149-5p can inhibit the development of PCa by targeting and inhibiting RGS17.